AU2005318126B2 — Indolidone derivatives for the treatment or prevention of fibrotic diseases
Assigned to Boehringer Ingelheim International GmbH · Expires 2011-11-24 · 14y expired
What this patent protects
The present invention relates to the use of indolinones of general formula (I) substituted in the 6 position, wherein R to R and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prev…
USPTO Abstract
The present invention relates to the use of indolinones of general formula (I) substituted in the 6 position, wherein R to R and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof, as a medicament for the prevention or treatment of specific fibrotic diseases.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.